Kolbeck Roland Wilhelm has filed 4 insider transactions across 1 company since August 2025.
Most recent transaction: a grant/award of 95700 shares of Aclaris Therapeutics, Inc. ($ACRS) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Kolbeck Roland Wilhelm | Chief Scientific Officer | A | Restricted Stock Units | 95700 | $0.00 | 95,700.0000 | 122,564,741 | 9999.99% | 0.08% |
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Kolbeck Roland Wilhelm | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 334900 | $0.00 | 334,900.0000 | 122,564,741 | 9999.99% | 0.27% |
| Aug. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Kolbeck Roland Wilhelm | Chief Scientific Officer | A | Restricted Stock Units | 145500 | $0.00 | 145,500.0000 | 122,580,967 | 9999.99% | 0.12% |
| Aug. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Kolbeck Roland Wilhelm | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 510000 | $0.00 | 510,000.0000 | 122,580,967 | 9999.99% | 0.42% |